+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biological Safety Testing Products & Services Market Analysis Report By Product (Reagents & Kits, Instruments, Services), By Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), By Test By Region, And Segment Forecasts, 2019 - 2026

  • ID: 4582082
  • Report
  • September 2019
  • Region: Global
  • 120 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Avance Biosciences
  • Creative Biogene
  • Cytovance Biologics
  • Lonza Group AG
  • MilliporeSigma
  • Samsung BioLogics
  • MORE
The global biological safety testing products and services market size is expected to reach a value of USD 6.9 billion by 2026, according to this report, exhibiting a CAGR of 12.3% The market is predominantly driven by increasing production of biologics, which is boosting the need for highly efficient biological safety testing tools. Rising disease burden is expected to be a major factor responsible for high production of biologics, thereby contributing to market growth.

Increasing prevalence of lifestyle-associated chronic diseases such as cancer and diabetes is a key factor contributing to rise in drug development and subsequent commercialization. This is expected to increase the need for scrutinizing & ensuring safety of targeted and specialized therapies, evaluating outcomes, and circumventing probable shortcomings. In addition, pharmaceutical and biotechnology companies are increasingly incorporating biological safety testing products and services to produce highly potent and contamination-free biologics to cater to the large number of people suffering from target diseases. Viral safety testing is proving to be one of the primary concerns of most companies as it is a critical component of chemistry, manufacturing, and control of biologics. This is creating growth opportunities in the market.

Laboratory-based contamination is leading to development and refinement of workstations through incorporation of biological safety products and services. Increasing need to work with tissue cultures, maintain sterility of cell lines, and minimize cross-contamination has increased concerns regarding product integrity. Rising intervention by government healthcare organizations to implement good manufacturing practices and subsequent testing & control at every production stage is expected to widen the scope for growth.

Further key findings from the study suggest:
  • On the basis of product, reagents and kits accounted for the largest share in 2018 as they are major components that are extensively used in research and clinical laboratories
  • The instruments segment, on the other hand, is expected to grow at a lucrative CAGR during the forecast period due to rising demand from various clinical and research laboratories
  • On the basis of application, vaccines & therapeutics segment is expected to grow at a significant CAGR during the forecast period mainly owing to increase in disease outbreaks over the years
  • Bioburden tests are expected to grow at a lucrative rate during the forecast period owing to their high adoption to determine bioburden limit in a wide range of biologics and medical devices
  • North America dominated the global biological safety testing products and services market in 2018 owing to high R&D investments in biotechnology and huge chronic disease burden
  • Asia Pacific is expected to grow at an exponential CAGR during the forecast period owing to increase in healthcare spending
  • Some of the key players are Charles River Laboratories International, Inc.; Lonza Group AG; MilliporeSigma; SGS SA; Sartorius Stedim BioOutsource Limited; and BSL Bioservice Scientific Laboratories GmbH.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Avance Biosciences
  • Creative Biogene
  • Cytovance Biologics
  • Lonza Group AG
  • MilliporeSigma
  • Samsung BioLogics
  • MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third-party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.3.1 Reimbursement framework
3.3.2 Standards & compliances
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing number of government initiatives and recommendations
3.4.1.2 Increasing production of new biologics due to high disease burden
3.4.1.3 High R&D investments in clinical research and life sciences research
3.4.2 Market restraint analysis
3.4.2.1 Time-consuming approval process
3.4.3 Industry opportunity
3.4.4 Industry challenges
3.4.4.1 Challenges pertaining to biosafety and biosecurity in less developed countries
3.5 Biological Safety Testing Products & Services Market Analysis Tools
3.5.1 Industry analysis-Porter’s
3.5.1.1 Supplier power
3.5.1.2 Buyer power
3.5.1.3 Substitution threat
3.5.1.4 Threat from new entrant
3.5.1.5 Competitive rivalry
3.5.2 PESTEL analysis
3.5.2.1 Political landscape
3.5.2.2 Environmental landscape
3.5.2.3 Social landscape
3.5.2.4 Technology landscape
3.5.2.5 Legal landscape
3.5.3 Major deals & strategic alliances analysis
3.5.4 Market entry strategies

Chapter 4 Biological Safety Testing Products & Services Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key customers
4.2.3 Key company market share analysis, 2018
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Company market share/ranking, by region
4.3.3 Competitive dashboard analysis
4.3.3.1 Market differentiators
4.4 Private companies
4.4.1 List of key emerging companies’/technology disruptors/innovators
4.4.2 Regional network map
4.4.3 Company market position analysis

Chapter 5 Biological Safety Testing Products & Services Market: Product Estimates and Trend Analysis
5.1 Definition and Scope
5.2 Products & Services Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Biological Safety Testing Products & Services Market, by Product, 2015-2026 (USD Million)
5.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Product
5.5.1 Reagents & kits
5.5.1.1 Reagents & kits market, 2015-2026 (USD Million)
5.5.2 Services
5.5.2.1 Services market, 2015-2026 (USD Million)
5.5.3 Instruments
5.5.3.1 Instruments market, 2015-2026 (USD Million)

Chapter 6 Biological Safety Testing Products & Services Market: Application Estimates and Trend Analysis
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Biological Safety Testing Products & Services Market, by Application, 2015-2026 (USD Million)
6.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Application
6.5.1 Stem cell
6.5.1.1 Stem cell market, 2015-2026 (USD Million)
6.5.2 Tissue & tissue-based products
6.5.2.1 Tissue & tissue-based products market, 2015-2026 (USD Million)
6.5.3 Gene therapy
6.5.3.1 Gene therapy market, 2015-2026 (USD Million)
6.5.4 Blood & blood-based products
6.5.4.1 Blood & blood-based products market, 2015-2026 (USD Million)
6.5.5 Vaccines & therapeutics
6.5.5.1 Vaccines & therapeutics market, 2015-2026 (USD Million)

Chapter 7 Biological Safety Testing Products & Services Market: Test Type Estimates and Trend Analysis
7.1 Definition and Scope
7.2 Test Type Market Share Analysis, 2018 & 2026
7.3 Segment Dashboard
7.4 Global Biological Safety Testing Products & Services Market, by Test Type, 2015-2026 (USD Million)
7.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Test Type
7.5.1 Sterility tests
7.5.1.1 Sterility tests market, 2015-2026 (USD Million)
7.5.2 Cell Line authentication and characterization tests
7.5.2.1 Cell line authentication and characterization tests market, 2015-2026 (USD Million)
7.5.3 Bioburden Tests
7.5.3.1 Bioburden tests market, 2015-2026 (USD Million)
7.5.4 Endotoxin Tests
7.5.4.1 Endotoxin tests market, 2015-2026 (USD Million)
7.5.5 Adventitious agent detection tests
7.5.4.1 Adventitious agent detection tests market, 2015-2026 (USD Million)
7.5.6 Residual host contamination detection tests
7.5.4.1 Residual host contamination detection tests market, 2015-2026 (USD Million)
7.5.7 Others Test Types
7.5.4.1 Others test types market, 2015-2026 (USD Million)

Chapter 8 Biological Safety Testing Products & Services Market Regional Estimates & Trend Analysis, by Product, Application, Test Type
8.1 Regional Market Snapshot
8.2 Regional Market Share and Leading Players, 2018
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa
8.3 Market Share Analysis by Country/State
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
8.4.1 North America
8.4.2 Europe
8.4.3 Asia Pacific
8.4.4 Latin America
8.4.5 Middle East & Africa
8.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026
8.6 North America
8.6.1 North America market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.6.2 U.S.
8.6.2.1 U.S. market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.6.3 Canada
8.6.3.1 Canada market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.7 Europe
8.7.1 Europe market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.7.2 Germany
8.7.2.1 Germany market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.7.3 UK
8.7.3.1 UK market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.7.4 France
8.7.4.1 France market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.7.5 Italy
8.7.5.1 Italy market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.7.6 Spain
8.7.6.1 Spain market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.7.7 Russia
8.7.7.1 Russia market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.8 Asia Pacific
8.8.1 Asia Pacific market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.8.2 Japan
8.8.2.1 Japan market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.8.3 China
8.8.3.1 China market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.8.4 India
8.8.4.1 India market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.8.5 South Korea
8.8.6.1 South Korea market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.8.7 Australia
8.8.7.1 Australia market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.8.8 Singapore
8.8.8.1 Singapore market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.9 Latin America
8.9.1 Latin America market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.9.2 Brazil
8.9.2.1 Brazil market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.9.3 Mexico
8.9.3.1 Mexico market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.9.4 Argentina
8.9.4.1 Argentina market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.10 Middle East and Africa
8.10.1 Middle East and Africa market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.10.2 South Africa
8.10.2.1 South Africa market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.10.3 Saudi Arabia
8.10.3.1 Saudi Arabia market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
8.10.4 UAE
8.10.4.1 UAE market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)

Chapter 9 COMPANY PROFILES
9.1 Charles River Laboratories International, Inc.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 BSL Bioservice Scientific Laboratories GmbH
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Lonza Group AG
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Cytovance Biologics
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 MilliporeSigma
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 SGS SA
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 Sartorius Stedim BioOutsource Limited
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Toxikon Corporation
9.8.1 Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.9 WuXi Biologics (Cayman), Inc.
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Avance Biosciences
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.11 Creative Biogene
9.11.1 Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.12 VIRUSURE
9.12.1 Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.13 Samsung BioLogics
9.13.1 Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.14 TOYOBO CO., LTD.
9.14.1 Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives

Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Charles River Laboratories International, Inc.
  • BSL Bioservice Scientific Laboratories GmbH
  • Lonza Group AG
  • Cytovance Biologics
  • MilliporeSigma
  • SGS SA
  • Sartorius Stedim BioOutsource Limited
  • Toxikon Corporation
  • WuXi Biologics (Cayman), Inc.
  • Avance Biosciences
  • Creative Biogene
  • VIRUSURE
  • Samsung BioLogics
  • TOYOBO CO., LTD.
Note: Product cover images may vary from those shown
Adroll
adroll